301 related articles for article (PubMed ID: 31630432)
1. Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management.
Wu JH; Cohen BA; Sweren RJ
Pediatr Dermatol; 2020 Jan; 37(1):18-28. PubMed ID: 31630432
[TBL] [Abstract][Full Text] [Related]
2. Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management.
Kothari R; Szepietowski JC; Bagot M; Sandhu S; Patil A; Grabbe S; Goldust M
Int J Dermatol; 2022 Dec; 61(12):1458-1466. PubMed ID: 35193164
[TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides: classic disease and variant presentations.
Howard MS; Smoller BR
Semin Cutan Med Surg; 2000 Jun; 19(2):91-9. PubMed ID: 10892710
[TBL] [Abstract][Full Text] [Related]
4. Mycosis fungoides variants-clinicopathologic features, differential diagnosis, and treatment.
Willemze R
Semin Cutan Med Surg; 2018 Mar; 37(1):11-17. PubMed ID: 29719015
[TBL] [Abstract][Full Text] [Related]
5. Perplexing Rash: Challenges to Diagnosis and Management of Mycosis Fungoides.
Aun JA; Patel HS; Patel KK; Cashman J; Bailey E
J Am Osteopath Assoc; 2018 Jul; 118(7):472-478. PubMed ID: 29946665
[TBL] [Abstract][Full Text] [Related]
6. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis, staging, and treatment options for mycosis fungoides.
Keehn CA; Belongie IP; Shistik G; Fenske NA; Glass LF
Cancer Control; 2007 Apr; 14(2):102-11. PubMed ID: 17387295
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
10. Clinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides.
Horwitz SM; Duvic M; Hsi ED
Clin Adv Hematol Oncol; 2010 Dec; 8(12):1-15. PubMed ID: 21344783
[TBL] [Abstract][Full Text] [Related]
11. Updated review on prognostic factors in mycosis fungoides and new skin lymphoma trials.
Farabi B; Seminario-Vidal L; Jamgochian M; Akay BN; Atak MF; Rao BK; Karagaiah P; Grabbe S; Goldust M
J Cosmet Dermatol; 2022 Jul; 21(7):2742-2748. PubMed ID: 34687485
[TBL] [Abstract][Full Text] [Related]
12. Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides.
Jung JM; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
Leuk Lymphoma; 2022 Jul; 63(7):1598-1606. PubMed ID: 35201905
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and prognostic factors of 114 patients with mycosis fungoides in a Moroccan cohort: a 29-year review.
Titou H; Bouhamidi A
Clin Exp Med; 2023 Nov; 23(7):3751-3758. PubMed ID: 37029872
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of mycosis fungoides.
Galper SL; Smith BD; Wilson LD
Oncology (Williston Park); 2010 May; 24(6):491-501. PubMed ID: 20568590
[TBL] [Abstract][Full Text] [Related]
15. Profile of mycosis fungoides in 43 Saudi patients.
AlGhamdi KM; Arafah MM; Al-Mubarak LA; Khachemoune A; Al-Saif FM
Ann Saudi Med; 2012; 32(3):283-7. PubMed ID: 22588440
[TBL] [Abstract][Full Text] [Related]
16. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
[TBL] [Abstract][Full Text] [Related]
17. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.
Doerschner M; Pekar-Lukacs A; Messerli-Odermatt O; Dommann-Scherrer C; Rütti M; Müller AM; Nair G; Kamarachev J; Kerl K; Beer M; Messerli M; Frauenknecht K; Haralambieva E; Hoetzenecker W; French LE; Guenova E
Br J Dermatol; 2019 Dec; 181(6):1296-1302. PubMed ID: 30565216
[TBL] [Abstract][Full Text] [Related]
18. Mycosis fungoides and the Sézary syndrome.
Kim YH; Hoppe RT
Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
[TBL] [Abstract][Full Text] [Related]
19. Pediatric mycosis fungoides in Singapore: a series of 46 children.
Heng YK; Koh MJ; Giam YC; Tang MB; Chong WS; Tan SH
Pediatr Dermatol; 2014; 31(4):477-82. PubMed ID: 24890628
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis.
Seyed Jafari SM; Cazzaniga S; Hunger RE
G Ital Dermatol Venereol; 2018 Dec; 153(6):827-832. PubMed ID: 29683282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]